These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2521197)
41. [Genetic analysis of the structure of the predisposition to diabetes mellitus. II. The prevalence, morbidity and heritability of diabetes mellitus]. Kerimi NB; Sergeev AS; Mazovetskiĭ AG; Kuraeva TL; Izhevskiĭ PV Genetika; 1984 Jan; 20(1):166-76. PubMed ID: 6538156 [TBL] [Abstract][Full Text] [Related]
43. HIV-1 infection among female commercial sex workers in rural Thailand. Gray JA; Dore GJ; Li Y; Supawitkul S; Effler P; Kaldor JM AIDS; 1997 Jan; 11(1):89-94. PubMed ID: 9110080 [TBL] [Abstract][Full Text] [Related]
44. Two models for a maternal factor in the inheritance of Huntington disease. Boehnke M; Conneally PM; Lange K Am J Hum Genet; 1983 Sep; 35(5):845-60. PubMed ID: 6225335 [TBL] [Abstract][Full Text] [Related]
45. Informativeness of Early Huntington Disease Signs about Gene Status. Oster E; Eberly SW; Dorsey ER; Kayson-Rubin E; Oakes D; Shoulson I J Huntingtons Dis; 2015; 4(3):271-7. PubMed ID: 26444024 [TBL] [Abstract][Full Text] [Related]
46. Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study. Prins M; Veugelers PJ AIDS; 1997 Apr; 11(5):621-31. PubMed ID: 9108944 [TBL] [Abstract][Full Text] [Related]
47. Prevalence and incidence of syphilis and its association with HIV-1 infection in a population-based study in the Kagera region of Tanzania. Killewo JZ; Sandström A; Bredberg Råden U; Mhalu FS; Biberfeld G; Wall S Int J STD AIDS; 1994; 5(6):424-31. PubMed ID: 7849121 [TBL] [Abstract][Full Text] [Related]
48. Seroconversion to HBV associated with seroconversion to HIV in a cohort of intravenous drug misusers in Turin, Italy. Sinicco A; Fora R; Sciandra M; Raiteri R Eur J Epidemiol; 1995 Oct; 11(5):535-9. PubMed ID: 8549727 [TBL] [Abstract][Full Text] [Related]
49. The bingo model of survivorship. II: statistical aspects of the bingo model of multiplicity 1 with application to hereditary polyposis of the colon. Morales AJ; Murphy EA; Krush AJ Am J Med Genet; 1984 Apr; 17(4):783-801. PubMed ID: 6720745 [TBL] [Abstract][Full Text] [Related]
50. Biological impact of recurrent sexually transmitted infections on HIV seroconversion among women in South Africa: results from frailty models. Wand H; Ramjee G J Int AIDS Soc; 2015; 18(1):19866. PubMed ID: 25912181 [TBL] [Abstract][Full Text] [Related]
51. Determinants of progression of HIV infection in a Greek hemophilia cohort followed for up to 16 years after seroconversion. Touloumi G; Karafoulidou A; Gialeraki A; Katsarou O; Milona I; Kapsimali V; Mandalaki T; Hatzakis A J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Sep; 19(1):89-97. PubMed ID: 9732075 [TBL] [Abstract][Full Text] [Related]
52. [Population-demographic and clinico-genetic characteristics of Huntington chorea in one region of Azerbaijan]. Kozlova SI; Dadali EL; Prytkov AN; Bol'shakova LP; Sibiriakova LG Genetika; 1986 Oct; 22(10):2534-9. PubMed ID: 2947830 [TBL] [Abstract][Full Text] [Related]
53. HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort. Peterson TA; Kimani J; Wachihi C; Bielawny T; Mendoza L; Thavaneswaran S; Narayansingh MJ; Kariri T; Liang B; Ball TB; Ngugi EN; Plummer FA; Luo M Tissue Antigens; 2013 Feb; 81(2):93-107. PubMed ID: 23330720 [TBL] [Abstract][Full Text] [Related]
54. HIV transmissions during seroconversion contribute significantly to new infections in men who have sex with men in Australia. Chibo D; Kaye M; Birch C AIDS Res Hum Retroviruses; 2012 May; 28(5):460-4. PubMed ID: 21806486 [TBL] [Abstract][Full Text] [Related]
55. Testing bias in calculating HIV incidence from the Serologic Testing Algorithm for Recent HIV Seroconversion. Remis RS; Palmer RW AIDS; 2009 Feb; 23(4):493-503. PubMed ID: 19240458 [TBL] [Abstract][Full Text] [Related]
56. Determinants of survival following HIV-1 seroconversion after the introduction of HAART. Porter K; Babiker A; Bhaskaran K; Darbyshire J; Pezzotti P; Porter K; Walker AS; Lancet; 2003 Oct; 362(9392):1267-74. PubMed ID: 14575971 [TBL] [Abstract][Full Text] [Related]
57. Risk of HIV infection as a function of the duration of intravenous drug use: a non-parametric Bayesian approach. Gómez G; Luz Calle M; Egea JM; Muga R Stat Med; 2000 Oct; 19(19):2641-56. PubMed ID: 10986539 [TBL] [Abstract][Full Text] [Related]
58. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation]. Vanuzzo D; Pilotto L; Mirolo R; Pirelli S G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746 [TBL] [Abstract][Full Text] [Related]
59. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach. Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454 [TBL] [Abstract][Full Text] [Related]
60. Daily alcohol use as an independent risk factor for HIV seroconversion among people who inject drugs. Young SV; Wood E; Dong H; Kerr T; Hayashi K Addiction; 2016 Aug; 111(8):1360-5. PubMed ID: 26639363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]